Ai Peng
- Molecular Biology
- Cancer Research top 5%
- Oncology
- Radiology, Nuclear Medicine and Imaging
- Pulmonary and Respiratory Medicine
- Topics
- Cancer, Lipids, and Metabolism (9 papers)Cancer-related molecular mechanisms research (6 papers)Peroxisome Proliferator-Activated Receptors (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ai Peng
33 papers receiving 938 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 513
- Cancer Research 329
- Oncology 124
- Radiology, Nuclear Medicine and Imaging 108
- Pulmonary and Respiratory Medicine 95
Countries citing papers authored by Ai Peng
This map shows the geographic impact of Ai Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai Peng more than expected).
Fields of papers citing papers by Ai Peng
This network shows the impact of papers produced by Ai Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai Peng. The network helps show where Ai Peng may publish in the future.
Co-authorship network of co-authors of Ai Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Ai Peng. A scholar is included among the top collaborators of Ai Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai Peng. Ai Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironmentbreakdown → | 144 |
| 3 | 14 | |
| 4 | 8 | |
| 5 | 10 | |
| 6 | 33 | |
| 7 | 22 | |
| 8 | 4 | |
| 9 | 20 | |
| 10 | 20 | |
| 11 | 8 | |
| 12 | 101 | |
| 13 | 6 | |
| 14 | 67 | |
| 15 | 20 | |
| 16 | 26 | |
| 17 | 70 | |
| 18 | 36 | |
| 19 | 33 | |
| 20 | 33 |
About Ai Peng
Ai Peng is a scholar working on Cancer Research, Nephrology and Developmental Neuroscience, having authored 34 papers that have together received 946 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (9 papers), Cancer-related molecular mechanisms research (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Cancer Research (329 citations), Nephrology (60 citations) and Molecular Biology (513 citations). Ai Peng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhili Liu, Shan Huang, Yang Zhou, Yong Gu, Jian Mao, Song Shen, Tianyong Sun, Linna Liu, Hui‐Xiong Xu and Le‐Hang Guo. Their work appears in journals such as PLoS ONE, Brain Research and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.